Burning Rock Biotech Ltd (BNR) Insider Trading Disclosures
Burning Rock Biotech Ltd (BNR) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BNR
CIK: 1792267
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young Hua Ming LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerChong Liu
Audit LocationShanghai, China
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-10 | 2026-09-10 | FORM 6-K | 0001193125-26-387190 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-11 | 4 | 0001193125-26-293511 | View SEC Doc Filr Page |
| 6-K | 2026-06-09 | 2026-06-09 | FORM 6-K | 0001193125-26-262871 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001907884-26-000011 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0000898432-26-000365 | View SEC Doc Filr Page |
| 20-F | 2026-04-28 | 2025-12-31 | FORM 20-F | 0001193125-26-183377 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | 4 | 0001193125-26-138961 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 | 0001193125-26-114717 | View SEC Doc Filr Page |
| 3 | 2026-03-17 | 2026-03-17 | 3 | 0001193125-26-109676 | View SEC Doc Filr Page |
| 3 | 2026-03-17 | 2026-03-17 | 3 | 0001193125-26-109672 | View SEC Doc Filr Page |
| 3 | 2026-03-17 | 2026-03-17 | 3 | 0001193125-26-109656 | View SEC Doc Filr Page |
| 3 | 2026-03-17 | 2026-03-17 | 3 | 0001193125-26-109641 | View SEC Doc Filr Page |
| 3 | 2026-03-17 | 2026-03-17 | 3 | 0001193125-26-109630 | View SEC Doc Filr Page |
| 6-K | 2026-03-13 | 2026-03-12 | FORM 6-K | 0001193125-26-104743 | View SEC Doc Filr Page |
| 6-K | 2025-12-23 | 2025-12-23 | FORM 6-K | 0001193125-25-329450 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-12-19 | — | SCHEDULE 13G Filing | 0000898432-25-001050 | View SEC Doc Filr Page |
| 6-K | 2025-12-01 | 2025-12-01 | FORM 6-K | 0001193125-25-303306 | View SEC Doc Filr Page |
| 6-K | 2025-11-20 | 2025-11-20 | FORM 6-K | 0001193125-25-288773 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-14 | — | SCHEDULE 13G/A Filing | 0001907884-25-000005 | View SEC Doc Filr Page |
| 6-K | 2025-09-08 | 2025-09-08 | FORM 6-K | 0001193125-25-197601 | View SEC Doc Filr Page |
| 6-K | 2025-06-06 | 2025-06-06 | FORM 6-K | 0001193125-25-136266 | View SEC Doc Filr Page |
| 20-F | 2025-04-29 | 2024-12-31 | FORM 20-F | 0001193125-25-101753 | View SEC Doc Filr Page |
| 6-K | 2025-03-25 | 2025-03-25 | FORM 6-K | 0001193125-25-061952 | View SEC Doc Filr Page |
| 6-K | 2024-12-31 | 2024-12-31 | FORM 6-K | 0001193125-24-287054 | View SEC Doc Filr Page |
| 6-K | 2024-12-04 | 2024-12-04 | FORM 6-K | 0001193125-24-270284 | View SEC Doc Filr Page |